Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Addiction stigma and the production of impediments to take-home naloxone uptake
Renae Fomiatti, Adrian Farrugia, Suzanne Fraser, et al.
Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine (2020) Vol. 26, Iss. 2, pp. 139-161
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy
Ali Cheetham, Louisa Picco, Anthony Barnett, et al.
Substance Abuse and Rehabilitation (2022) Vol. Volume 13, pp. 1-12
Open Access | Times Cited: 117
How do relational practices co-constitute care for people who use drugs? The social and political dimensions of peer-led harm reduction
Timothy Piatkowski, Kate Seear, Steph Reeve, et al.
International Journal of Drug Policy (2024) Vol. 133, pp. 104614-104614
Open Access | Times Cited: 7
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply
Wai Chung Tse, Filip Djordjevic, Viandro Borja, et al.
International Journal of Drug Policy (2021) Vol. 100, pp. 103513-103513
Closed Access | Times Cited: 38
Categorizing Stigma as a Barrier to Support Following Nonfatal Overdose: A Qualitative Study
Kaylee Larsen, Sydney M. Silverstein, Timothy N. Crawford, et al.
Journal of Addiction Medicine (2025)
Closed Access
Mapping the risk environment for peers with lived-living experience working in the alcohol and other drugs sector in Queensland
Timothy Piatkowski, Emma Kill, Cameron Duff, et al.
International Journal of Drug Policy (2025) Vol. 137, pp. 104725-104725
Open Access
Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
Samuel O. Adeosun
Journal of Pharmacy Practice (2022) Vol. 36, Iss. 4, pp. 941-952
Closed Access | Times Cited: 14
Naloxone Knowledge and Attitudes Towards Overdose Response Among Family Members of People who Misuse Opioids
Stella M. Resko, Emily Pasman, Danielle Hicks, et al.
Journal of Community Health (2023) Vol. 49, Iss. 1, pp. 70-77
Closed Access | Times Cited: 8
“It can save your life, that’s all I know,” barriers and facilitators for engagement in take-home naloxone for people receiving opioid substitution treatment in regional Australia: An explorative study
Isabella Natale, Craig Harvey, Penelope Wood, et al.
Qualitative Research in Medicine & Healthcare (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 8
A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin
Antoinette L. Spector, Carol L. Galletly, Erika Christenson, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Implementation and Evaluation of a Bystander Naloxone Training Course.
Scott G. Weiner, Scott A. Goldberg, Cheryl Lang, et al.
PubMed (2024) Vol. 25, Iss. 3, pp. 320-324
Closed Access | Times Cited: 2
Correlates of stocking naloxone: a cross-sectional survey of community pharmacists
Rose Laing, Ting Xia, Elizabeth Grist, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1362-1370
Open Access | Times Cited: 2
Practical implications of naloxone knowledge among suburban people who use opioids
Kristin E. Schneider, Glenna J. Urquhart, Saba Rouhani, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 14
The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid‐related deaths: findings from a modelling study
Suzanne Nielsen, Nick Scott, Tom Tidhar, et al.
Addiction (2021) Vol. 117, Iss. 4, pp. 1009-1019
Open Access | Times Cited: 14
Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey
Lindsey Hohmann, Zach Krauss, Jitisha Patel, et al.
Pharmacy (2022) Vol. 10, Iss. 6, pp. 171-171
Open Access | Times Cited: 9
If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study
Susannah Slocum, Jenny E. Ozga, Rebecca Joyce, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Compassion matters: Opening a window to improve care for patients with opioid use disorder
Megan E. Heeney, Harrison Alter
Academic Emergency Medicine (2024)
Closed Access | Times Cited: 1
Understanding preferences for type of take-home naloxone device: international qualitative analysis of the views of people who use opioids
Joanne Neale, Adrian Farrugia, Aimee Campbell, et al.
Drugs Education Prevention and Policy (2021) Vol. 29, Iss. 2, pp. 109-120
Open Access | Times Cited: 9
The Impact of Naloxone Coprescribing Mandates on Opioid-Involved Overdose Deaths
Minji Sohn, Chris Delcher, Jeffery Talbert, et al.
American Journal of Preventive Medicine (2022) Vol. 64, Iss. 4, pp. 483-491
Closed Access | Times Cited: 6
Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic
Jeanette M. Bowles, Gillian Kolla, Laramie R. Smith, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100167-100167
Open Access | Times Cited: 3
Stigma is stopping an evidence based response to drug overdose deaths in the UK
Andy Guise, Magdalena Harris, Martin McCusker, et al.
BMJ (2023), pp. e074934-e074934
Closed Access | Times Cited: 3
The effects of race and class on community-level stigmatization of opioid use and policy preferences
David Chavanne, Jasjit S. Ahluwalia, Kimberly Goodyear
International Journal of Drug Policy (2023) Vol. 120, pp. 104147-104147
Closed Access | Times Cited: 3
“I wanted to close the chapter completely … and I feel like that [carrying naloxone] would keep it open a little bit”: Refusal to carry naloxone among newly-abstinent opioid users and 12-step identity
Jeanette M. Bowles, Laramie R. Smith, María Luisa Mittal, et al.
International Journal of Drug Policy (2021) Vol. 94, pp. 103200-103200
Open Access | Times Cited: 8
Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access
Sara S. McMillan, Hidy Chan, Laetitia Hattingh
Pharmacy (2021) Vol. 9, Iss. 2, pp. 95-95
Open Access | Times Cited: 8
Pharmacists’ experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study
Robin A. Pollini, Susannah Slocum, Jenny E. Ozga, et al.
Journal of the American Pharmacists Association (2021) Vol. 62, Iss. 1, pp. 157-166
Open Access | Times Cited: 8
Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact
John Strang
European Addiction Research (2021) Vol. 28, Iss. 3, pp. 161-175
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top